- Home
- AMS vs CTXR Comparison
AMS vs CTXR Comparison
Compare AMS & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- CTXR
- Stock Information
- Founded
- AMS 1980
- CTXR 2007
- Country
- AMS United States
- CTXR United States
- Employees
- AMS N/A
- CTXR N/A
- Industry
- AMS Medical Specialities
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- AMS Health Care
- CTXR Health Care
- Exchange
- AMS Nasdaq
- CTXR Nasdaq
- Market Cap
- AMS 17.9M
- CTXR 14.6M
- IPO Year
- AMS N/A
- CTXR N/A
- Fundamental
- Price
- AMS $2.98
- CTXR $0.94
- Analyst Decision
- AMS
- CTXR Strong Buy
- Analyst Count
- AMS 0
- CTXR 2
- Target Price
- AMS N/A
- CTXR $54.50
- AVG Volume (30 Days)
- AMS 7.0K
- CTXR 142.3K
- Earning Date
- AMS 05-15-2025
- CTXR 05-23-2025
- Dividend Yield
- AMS N/A
- CTXR N/A
- EPS Growth
- AMS 243.96
- CTXR N/A
- EPS
- AMS 0.33
- CTXR N/A
- Revenue
- AMS $28,340,000.00
- CTXR N/A
- Revenue This Year
- AMS $23.63
- CTXR N/A
- Revenue Next Year
- AMS N/A
- CTXR N/A
- P/E Ratio
- AMS $8.76
- CTXR N/A
- Revenue Growth
- AMS 32.90
- CTXR N/A
- 52 Week Low
- AMS $2.51
- CTXR $0.68
- 52 Week High
- AMS $4.60
- CTXR $26.25
- Technical
- Relative Strength Index (RSI)
- AMS 61.91
- CTXR 51.36
- Support Level
- AMS $2.68
- CTXR $0.65
- Resistance Level
- AMS $2.80
- CTXR $0.82
- Average True Range (ATR)
- AMS 0.08
- CTXR 0.09
- MACD
- AMS 0.02
- CTXR 0.04
- Stochastic Oscillator
- AMS 94.12
- CTXR 85.69
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.